Celltrion Adds Safety-Syringe Yuflyma Biosimilar to Korean Formulary at Lowest Adalimumab Price
· techtimes.com · popularity 21/100 · 0 similar stories today · Pharmaceuticals & Medical Research (Health & Life Sciences)
Read the original at techtimes.com →
Summary
Adalimumab biosimilar Yuflyma PFS-S from Celltrion Pharm joins South Korea's NHI formulary at 220,390 Korean won per dose -- the lowest reimbursed adalimumab price in Korea -- featuring a passive needle safety guard that deploys automatically after injection, filling the market gap left when Samsung Bioepis withdrew its Adalloce PFS prefilled syringe.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.